Content #1
Content #1
Content #1
Optimized and easy-to-use kit for extracting total RNA, including mRNA and miRNA, from purified EVs for downstream analysis in qPCR or RNAseq.
Obtaining high yields of quality RNA from extracellular vesicles (EVs) is a challenge due the dilute nature of EV samples and low RNA content within EVs. In addition, short non-coding RNAs within EVs, such as miRNAs, are commonly studied as biomarkers and often require specialized methods for efficient extraction. The ExoBrite™ EV Total RNA Isolation Kit was designed to address these challenges by offering an optimized and easy-to-use kit for total RNA isolation, including mRNA and miRNA, from purified EVs. The isolated EV RNA can then be used for downstream analysis such as qPCR or RNAseq.
The RNA isolation procedure is a simple column purification method that takes as little as 20 minutes and requires no phenol/chloroform or ethanol precipitation steps. The kit is estimated to recover
~10-20 ng of RNA from 1x1010 SEC-enriched EVs. The amount of RNA recovered will depend primarily on EV number and quality, which may be affected by purification method, storage conditions, and number of freeze thaws. An optional, but recommended, DNase treatment step is used to remove contaminating DNA.
Extracellular vesicles (EVs) are nanoscale, membrane-bound particles released by cells that play important roles in intercellular communication by transporting proteins, lipids, and nucleic acids. Bovine milk is an abundant and accessible source of extracellular vesicles with potential applications in therapeutic delivery, diagnostics, and biomedical research. However, efficiently isolating these vesicles from milk remains challenging due to the complexity of the biological matrix and limitations of conventional isolation methods. Conventional ultracentrifugation or size exclusion chromatography approaches can require expensive, specialized equipment and may produce lower yields or affect vesicle integrity. Developing simpler, scalable, and cost-effective isolation methods could make EV research more accessible to laboratories with limited resources.
In a 2026 BioTechniques publication, Whitney, L. et al. investigated a modified aqueous two-phase system (ATPS) for isolating and characterizing EVs from raw bovine milk. Biotium’s ExoBrite™ 645/675 True EV Membrane Stain was used to fluorescently label the isolated EV membranes for flow cytometry analysis. The researchers combined the membrane stain with antibodies against EV-associated proteins CD63 and TSG101 to confirm the presence and identity of the isolated vesicles. Flow cytometry detected substantial populations of CD63- and TSG101-positive EVs above background, supporting successful EV recovery using the ATPS approach. Additional characterization found that the isolated particles exhibited typical EV morphology and size, as well as protein, lipid, and nucleic acid profiles consistent with extracellular vesicles.
Together, these findings demonstrated that the modified ATPS method can recover intact, biologically relevant EVs from raw bovine milk while requiring less specialized equipment than conventional isolation approaches. These findings are promising toward expanding access to extracellular vesicle research and unlocking the therapeutic and biomedical potential of milk-derived EVs.
By providing reliable fluorescent tools for identifying and characterizing EV populations, Biotium’s ExoBrite™ True EV Membrane Stains can help researchers visualize and distinguish extracellular vesicles during flow cytometry and other analytical workflows, supporting research into EV biology, isolation methods, and potential applications in drug delivery and diagnostics.
Learn more about Biotium’s wide range of EV stains, including ExoBrite™ WGA, CTB, and Annexin V conjugates for bright and sensitive EV surface staining. Biotium also offers ExoBrite™ Flow Antibody Conjugates and ExoBrite™ Antibody Cocktails for optimized detection of EV Markers by flow and fNTA.

ExoBrite™ 645/675 True EV Membrane Stain was used to stain SEC EVs isolated from MCF-7 cells (left panel). The samples were run on a CytoFLEX LX flow cytometer in the R660 (APC) channel. The gated population shows that stained EVs are easily distinguished from background, compared to the dye in buffer alone (right panel).
Full Citation
Whitney, L. S., College, E. R., Peña-Ekker, J., Cannon, C. A., Mason, K. M., Wilson, J. N., & Pullan, J. E., PhD. (2026). Isolation and characterization of bovine-milk derived extracellular vesicles using a modified aqueous two-phase system. BioTechniques, 78(1–12), 55–64. https://doi.org/10.1080/07366205.2026.2633107
Extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs) are emerging as powerful, cell-free immunomodulatory therapies for inflammatory diseases such as COVID-19. However, because the mechanism is poorly understood, optimizing EV-based therapies remains challenging.
In a 2025 Springer Nature study, Infante et al. investigated how COVID-19 patient serum reshapes the transcriptome and paracrine activity of Wharton’s jelly–derived MSC stem cells (WJ-MSCs). WJ-MCSs exposed to serum from hospitalized COVID patients showed downregulation of NEAT1 and MALAT1, two pro-inflammatory two long noncoding RNAs (lncRNAs). Furthermore, the researchers found that EVs derived from the treated cells had enhanced immunosuppressive activity when administered to T-cells.
The researchers isolated EVs from WJ-MSC cells after NEAT1 and/or MALAT1 knockdown, and tested whether there was an effect on T-cell proliferation. A Western blot of EVs derived from control and lncRNA-knockdown MSCs were probed with ExoBrite™ 680/700 CD81 Western Antibody. ExoBrite™ 770/800 Calnexin Western Antibody was also used as an endoplasmic reticulum marker to assess cellular contamination.
EV enriched samples in control, NEAT1 knockdown, MALAT1 knockdown, and NEAT1/MALAT1-double knockdown were confirmed by bright CD81 detection and the absence of Calnexin. They found that the MALAT1 knockdown EVs were found to have an inhibitory effect on T-cell proliferation. These results illustrate the importance of EV characterization using tools like Biotium’s ExoBrite™ antibodies in translational EV research.

Isolation and characterization of EVs from various lncRNA knock-down WJ-MSCs. Western blot analysis using ExoBrite™ 680/700 CD81 and ExoBrite™ 770/800 Calnexin in EV and MSC lysates. Asterisk (*) indicates reduced conditions used in the MSCs lysate. Modified from Infante et. al. Reproduced under CC BY 4.0.
Learn more about Biotium’s many stains and antibodies for EV research, including ExoBrite™ CD9/CD63/CD81 Antibody Cocktails for flexible and bright multiplexing detection by flow cytometry. Biotium also offers ExoBrite™ stains for pan-EV labeling, optimized fluorescent conjugates of CTB, WGA, and Annexin V for EV detection, ExoBrite™ antibodies for STORM imaging, and more.
Full Citation:
Infante, A., Cabodevilla, L., Gener, B. et al. Modulation of NEAT1 and MALAT1 expression in WJ-MSCs by Covid-19 serum: a foundation for EVs-mediated therapy. Respir Res 26, 313 (2025). https://doi.org/10.1186/s12931-025-03394-4
While early studies of EVs attempted to use first-generation membrane dyes like DiI or PKH to stain EVs, more recently this class of dyes has been found to be largely unsuitable for EV staining due to their high degree of aggregation. Dye aggregation not only generates nonspecific particles that are indistinguishable from EVs in flow cytometry, but also results in poor EV labeling efficiency. Biotium developed the ExoBrite™ True EV Membrane Stains in response to our customers’ difficulties with using traditional membrane dyes to stain EVs. See our Literature Digest for more information.